These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Understanding HIV latency: the road to an HIV cure. Dahabieh MS; Battivelli E; Verdin E Annu Rev Med; 2015; 66():407-21. PubMed ID: 25587657 [TBL] [Abstract][Full Text] [Related]
67. Select host restriction factors are associated with HIV persistence during antiretroviral therapy. Abdel-Mohsen M; Wang C; Strain MC; Lada SM; Deng X; Cockerham LR; Pilcher CD; Hecht FM; Liegler T; Richman DD; Deeks SG; Pillai SK AIDS; 2015 Feb; 29(4):411-20. PubMed ID: 25602681 [TBL] [Abstract][Full Text] [Related]
68. Bioinformatics and HIV latency. Ciuffi A; Mohammadi P; Golumbeanu M; di Iulio J; Telenti A Curr HIV/AIDS Rep; 2015 Mar; 12(1):97-106. PubMed ID: 25586146 [TBL] [Abstract][Full Text] [Related]
69. The integrase cofactor LEDGF/p75 associates with Iws1 and Spt6 for postintegration silencing of HIV-1 gene expression in latently infected cells. Gérard A; Ségéral E; Naughtin M; Abdouni A; Charmeteau B; Cheynier R; Rain JC; Emiliani S Cell Host Microbe; 2015 Jan; 17(1):107-17. PubMed ID: 25590759 [TBL] [Abstract][Full Text] [Related]
70. HIV-1 integration landscape during latent and active infection. Cohn LB; Silva IT; Oliveira TY; Rosales RA; Parrish EH; Learn GH; Hahn BH; Czartoski JL; McElrath MJ; Lehmann C; Klein F; Caskey M; Walker BD; Siliciano JD; Siliciano RF; Jankovic M; Nussenzweig MC Cell; 2015 Jan; 160(3):420-32. PubMed ID: 25635456 [TBL] [Abstract][Full Text] [Related]
71. Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells. Kaczmarek Michaels K; Natarajan M; Euler Z; Alter G; Viglianti G; Henderson AJ J Immunol; 2015 Apr; 194(7):3267-74. PubMed ID: 25710909 [TBL] [Abstract][Full Text] [Related]
72. HIV Latency and the noncoding RNA therapeutic landscape. Saayman S; Roberts TC; Morris KV; Weinberg MS Adv Exp Med Biol; 2015; 848():169-89. PubMed ID: 25757621 [TBL] [Abstract][Full Text] [Related]
73. A hardwired HIV latency program. Razooky BS; Pai A; Aull K; Rouzine IM; Weinberger LS Cell; 2015 Feb; 160(5):990-1001. PubMed ID: 25723172 [TBL] [Abstract][Full Text] [Related]
74. HIV-1/HIV-2 versus SAMHD1 restriction: a tale of two viruses. Wei W; Yu XF Cell Host Microbe; 2015 Jan; 17(1):8-9. PubMed ID: 25590755 [TBL] [Abstract][Full Text] [Related]
75. Double trouble: HIV latency and CTL escape. Marsden MD; Zack JA Cell Host Microbe; 2015 Feb; 17(2):141-2. PubMed ID: 25674977 [TBL] [Abstract][Full Text] [Related]
76. An evolutionary role for HIV latency in enhancing viral transmission. Rouzine IM; Weinberger AD; Weinberger LS Cell; 2015 Feb; 160(5):1002-1012. PubMed ID: 25723173 [TBL] [Abstract][Full Text] [Related]
77. Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. Laird GM; Bullen CK; Rosenbloom DI; Martin AR; Hill AL; Durand CM; Siliciano JD; Siliciano RF J Clin Invest; 2015 May; 125(5):1901-12. PubMed ID: 25822022 [TBL] [Abstract][Full Text] [Related]
78. Eradication of HIV-1 from the macrophage reservoir: an uncertain goal? Abbas W; Tariq M; Iqbal M; Kumar A; Herbein G Viruses; 2015 Mar; 7(4):1578-98. PubMed ID: 25835530 [TBL] [Abstract][Full Text] [Related]
79. HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells. Chavez L; Calvanese V; Verdin E PLoS Pathog; 2015 Jun; 11(6):e1004955. PubMed ID: 26067822 [TBL] [Abstract][Full Text] [Related]